Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Revive Therapeutics Ltd (RVVTF)

Revive Therapeutics Ltd (RVVTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RVVTF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1310 +9.16%
on 10/29/20
0.2260 -36.73%
on 09/30/20
-0.0638 (-30.85%)
since 09/29/20
3-Month
0.1310 +9.16%
on 10/29/20
0.3940 -63.71%
on 08/03/20
-0.0426 (-22.95%)
since 07/29/20
52-Week
0.0173 +726.59%
on 12/16/19
0.5000 -71.40%
on 07/01/20
+0.1060 (+286.49%)
since 10/29/19

Most Recent Stories

More News
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders,...

RVVTF : 0.1430 (+5.15%)
InvestmentPitch Media Video Discusses Revive Therapeutics' supply agreement with Havn Life Sciences for Psychedelic Compounds - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - October 21, 2020) - Revive Therapeutics (CSE: RVV) (OTC PINK: RVVTF), a specialty life sciences company focused on the research and development of therapeutics...

HAVN.CN : 0.850 (-1.16%)
RVVTF : 0.1430 (+5.15%)
RVV.CN : 0.190 (+5.56%)
The Potential $100 Billion Psychedelics Boom Investors Should Watch

Much like cannabis, psychedelics are quickly going mainstream – and fast, most notably psilocybin. ...

RVVTF : 0.1430 (+5.15%)
HAVN.CN : 0.850 (-1.16%)
MMEDF : 0.7899 (-1.26%)
CMPS : 33.13 (+0.98%)
NUMI.VN : 0.460 (+8.24%)
JNJ : 137.19 (-0.85%)
RVV.CN : 0.190 (+5.56%)
Havn Life Sciences Signs Agreement to Supply Psychedelic Compounds for use in Research and Development to Revive Therapeutics

Havn Life will export naturally derived psilocybin to the United States for use in IND-enabling studies and future clinical trials under FDA guidelines

RVVTF : 0.1430 (+5.15%)
Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders,...

RVVTF : 0.1430 (+5.15%)
HAVN.CN : 0.850 (-1.16%)
The World May be Nearing Treatments for the Growing Pandemic

At the moment, the CV-19 pandemic shows no signs of slowing. To date, there are nearly 33.4 million ...

RVVTF : 0.1430 (+5.15%)
MRNA : 71.28 (+8.43%)
GILD : 58.53 (-0.32%)
REGN : 555.79 (-1.98%)
PFE : 35.28 (-0.48%)
RVV.CN : 0.190 (+5.56%)
Revive Therapeutics Announces Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders,...

RVVTF : 0.1430 (+5.15%)
Stocks in play: Revive Therapeutics Ltd.

Provided a corporate update on its psychedelics therapeutics programs specifically as it relates to ...

RVV.CN : 0.190 (+5.56%)
RVVTF : 0.1430 (+5.15%)
These Could be Some of the Most Valuable Psychedelic Stocks

Psychedelics, like psilocybin are going mainstream – and fast. Already, over the last few months, ...

CMPS : 33.13 (+0.98%)
RVVTF : 0.1430 (+5.15%)
MMEDF : 0.7899 (-1.26%)
NUMI.VN : 0.460 (+8.24%)
MCUR.CN : 0.600 (-3.23%)
HAVN.CN : 0.850 (-1.16%)
RVV.CN : 0.190 (+5.56%)
Compass Pathways' Leads the Way as the First Psychedelics Company To IPO on the Nasdaq

, /PRNewswire/ -- Last year may have been all about cannabis, but it's clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since (NYSE:JNJ) ketamine-derived medicine, Spravato,...

AGN : 193.02 (+0.02%)
RVVTF : 0.1430 (+5.15%)
JNJ : 137.19 (-0.85%)
CMPS : 33.13 (+0.98%)
RVV.CN : 0.190 (+5.56%)
ABBV : 80.67 (+0.22%)
MMEDF : 0.7899 (-1.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.1603
1st Resistance Point 0.1517
Last Price 0.1430
1st Support Level 0.1327
2nd Support Level 0.1223

See More

52-Week High 0.5000
Fibonacci 61.8% 0.3156
Fibonacci 50% 0.2587
Fibonacci 38.2% 0.2017
Last Price 0.1430
52-Week Low 0.0173

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar